For its list, published Aug. 11, GoodRx excluded drugs that have to be administered by a healthcare provider. The prices reflect list prices for the drug’s most common 30-day prescription.
The 20 most expensive drugs based on their monthly list prices:
1. Myalept — $71,306 (Amryt Pharma)
2. Ravicti — $55,341 (Horizon Therapeutics)
3. Mavenclad — $56,954 (EMD Serono)
4. Actimmune — $52,777 (Horizon Therapeutics)
5. Oxervate — $48,498 (Dompé)
6. Takhzyro — $45,464 (Takeda)
7. Juxtapid — $44,714 (Amryt Pharma)
8. Cinryze — $44,141 (Takeda)
9. Chenodal — $42,570 (Retrophin)
10. Gattex — $40,450 (Takeda)
11. H.P. Acthar — $39,864 (Mallinckrodt Pharmaceuticals)
12. Tegsedi — $34,600 (Akcea Therapeutics)
13. Vitrakvi — $32,800 (Bayer Pharmaceuticals)
14. Qinlock — $32,000 (Deciphera Pharmaceuticals)
15. Ayvakit — $32,000 (Blueprint Medicines)
16. Korlym — $31,440 (Corcept Therapeutics)
17. Sovaldi — $28,000 (Gilead)
18. Viekira Pak — $27,773 (AbbVie)
19. Tibsovo — $27,421 (Agios Pharmaceuticals)
20. Cerdelga — $27,300 (Genzyme Corp.)
More articles on pharmacy:
CVS HealthHub rollout resumes
Merck bets on one-shot vaccine
CVS, Walgreens & Costco sued for not filling opioid prescriptions
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
